Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape

American Journal of Hypertension

Volumn 17, Issue 5, 2004, Pages 395-403

  Hu, Lufei ^a   Sealey, Jean E ^a   Chen, Rong ^a   Zhou, Ying ^a   Merali, Carmen ^a   Shi, Yuexian ^a   Laragh, John H ^a   Catanzaro, Daniel F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II; Animal models; Hypertension; Nitric oxide; Target organ damage

Indexed keywords

ANGIOTENSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RENIN; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; FIBROSIS; HEART INJURY; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN INJURY; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT;

ANGIOTENSIN II; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBROSIS; INFUSIONS, INTRAVENOUS; KIDNEY; MODELS, CARDIOVASCULAR; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RENIN; TIME FACTORS; TROPONIN T; VASOCONSTRICTOR AGENTS;

EID: 1942436815     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.01.003     Document Type: Article

References (58)

1. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B., Griendling K., Harrison D. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation contribution to alterations of vasomotor tone. J Clin Invest. 97:1996;1916-1923.
2. Romero J.C., Reckelhoff J.F. State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 34:1999;943-949.
3. Zatz R., Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension. 32:1998;958-964.
4. Ribeiro M.O., Antunes E., De-Nucci G., Lovisolo S.M., Zatz R. Chronic inhibition of nitric oxide synthesis a new model of arterial hypertension. Hypertension. 20:1992;298-303.
5. Hu L., Catanzaro D.F., Pitarresi T.M., Laragh J.H., Sealey J.E. Identical hemodynamic and hormonal responses to 14-day infusions of renin or angiotensin II in conscious rats. J Hypertens. 16:1998;1285-1298.
6. Simon G., Abraham G., Cserep G. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am J Hypertens. 8:1995;645-650.
7. Ames R.P., Borkowski A.J., Sicinski A.M., Laragh J.H. Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest. 44:1965;1171-1186.
8. Hall J.E. Control of sodium excretion by angiotensin II intrarenal mechanisms and blood pressure regulation. Am J Physiol. 250:1986;R960-R972.
9. Dickinson C.J., Yu R. Mechanisms involved in the progressive pressor response to very small amounts of angiotensin in conscious rabbits. Circ Res. 20/21:(Suppl II):1967;II157-II163.
10. Cox B.F., Bishop V.S. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am J Physiol. 261:1991;H1284-H1291.
11. Reid I.A. Interactions between Ang II, sympathetic nervous system, and barorecepter reflexes in regulation of blood pressure. Am J Physiol. 262:1992;E763-E778.
12. Fink G.D., Bruner C.A., Mangiapane M.L. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension. 9:1987;355-361.
13. Lever A.F., Lyall F., Morton J.J., Folkow B. Angiotensin II, vascular structure and blood pressure. Kidney Intl. 41:1992;S51-S55.
14. Simon G., Abraham G. Angiotensin II administration as an experimental model of hypertension. Laragh J.H., Brenner B.M. Hypertension Pathophysiology, Diagnosis, and Management. 1995;1423-1435 Raven Press, New York.
15. Cowley A.W., DeClue J.W. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs. Circ Res. 39:1976;779-787.
16. Melaragno M.G., Fink G.D. Role of Ang II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats. Am J Physiol. 271:1996;806-811.
17. Hou J., Kato H., Cohen R.A., Chobanian A.V., Brecher P. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest. 96:1995;2469-2477.
18. Rocha R., Stier C.T., Kifor I., Ochoa-Maya M.R., Rennke H.G., Williams G.H., Adler G.K. Aldosterone a mediator of myocardial necrosis and renal arteriopathy. Endocrinology. 141:2000;3871-3878.
19. Hu L., Catanzaro D.F., Laragh J.H., Sealey J.E. Delayed recovery of hypertension after single dose losartan in Ang II-infused conscious rats. J. Hypertens. 17:1999;1443-1450.
20. Campbell W.G. Jr, Gahnem F., Catanzaro D.F., James G.D., Camargo M.J.F., Laragh J.H., Sealey J.E. Plasma and renal prorenin/renin, renin mRNA and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension. 27:1996;1121-1133.
21. Sealey J.E. Plasma renin activity and plasma prorenin assays. Clin Chem. 37:1991;1811-1819.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytic Biochem. 72:1976;248-254.
23. O'Brien P.J., Dameron G.W., Beck M.L., Kang Y.J., Erickson B.K., Di Battista T.H., Miller K.E., Jackson K.N., Mittelstadt S. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci. 47:1997;486-495.
24. Zacharowski K., Otto M., Hafner G., Chatterjee P.K., Thiemermann C. Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology. Arterioscler Thromb Vasc Biol. 19:1999;2276-2280.
25. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281.
26. Fujihara C.K., Michellazzo S.M., de Nucci G., Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol. 266:1994;F697-F705.
27. Yamada S.S., Sassaki A.L., Fujihara C.K., Malheiros D.M., De Nucci G., Zatz R. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension. 27:1996;1165-1172.
28. Palmer R.M.J., Ferrige A.J., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
29. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
30. Hu L., Manning R.D. Jr, Brands M.W. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 23:1994;185-194.
31. Manning R.D. Jr, Hu L., Mizelle H.L., Montani J.P., Norton M.W. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension. 22:1993;40-48.
32. Lee B.H., Shin H.S. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats. J Pharmacol. 74:1997;83-90.
33. Guan H., Cachofeiro V., Pucci M.L., Kaminski P.M., Wolin M.S., Nasjletti A. Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension. 27:1996;19-24.
34. Boulanger C.M., Caputo L., Levy B.I. Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 26:1995;752-757.
35. Patzak A., Mrowka R., Storch E., Hocher B., Persson P.B. Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol. 12:2001;1122-1127.
36. Brown A.J., Casals-Stenzel J., Gofford S., Lever A.F., Morton J.J. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 241:1981;H381-H388.
37. Gorbea-Oppliger V.J., Melaragno M.G., Potter G.S., Petit R.L., Fink G.D. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects. J Pharmacol Exp Therap. 271:1994;804-810.
38. Lever A.F. The fast and slowly developing pressor effects of angiotensin II. Ian J., Robertson S., Nicholls M.G. The Renin-Angiotensin System. 1993;28.1-28.9 Gower Medical, London.
39. Haas J.A., Krier J.D., Bolterman R.J., Juncos L.A., Romero J.C. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension. 34:1999;983-986.
40. Blumenfeld J.D., Sealey J.E., Mann S.J., Bragat A., Marion R., Pecker M.S., Sotelo J., August P., Pickering T.G., Laragh J.H. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin- aldosterone system in normotensive and hypertensive subjects. Am J Hypertens. 12:1999;451-459.
41. Martinez D., Rocha R., Matsumura M., Oestreicher E., Ochoa-Maya M., Roubsanthisuk W., Williams G., Adler G. Cardiac damage prevention by eplerenone comparison with low sodium diet or potassium loading. Hypertension. 39:2002;614-618.
42. Campbell S.E., Janicki J.S., Weber K.T. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol. 27:1995;1545-1560.
43. Volpe M., Camargo M.J.F., Mueller F.B., Campbell W.G. Jr, Sealey J.E., Pecker M.S., Sosa R.E., Laragh J.H. Relation of plasma renin to end-organ damage and to protection of K+ feeding in stroke-prone hypertensive rats. Hypertension. 15:1990;318-326.
44. von Lutterotti N., Camargo M.J.F., Campbell W.G. Jr, Mueller F.B., Timmermans P.B.M.W.M., Sealey J.E., Laragh J.H. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J Hypertens. 10:1992;949-957.
45. Gahnem F., von Lutterotti N., Camargo M.J.F., Laragh J.H., Sealey J.E. Angiotensinogen dependency of blood pressure of two high renin hypertensive rat models. Am J Hypertens. 7:1994;899-904.
46. Hayakawa H., Raij L. Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension. 31:1998;266-270.
47. Raij L. Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension. Semin Nephrol. 19:1999;296-303.
48. Hu L., Manning R.D. Jr. Role of nitric oxide in the regulation of the long-term pressure-natriuresis relationship in Dahl rats. Am J Physiol. 268:1995;PH2375-PH2383.
49. Ikeda Y., Saito K., Kim J.I., Yokoyama M. Nitric oxide synthase isoform activities in kidney of Dahl salt-sensitive rats. Hypertension. 26:1995;1030-1034.
50. Tan D.Y., Meng S., Manning R.D. Jr. Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension. Hypertension. 33:1999;456-461.
51. Linder L., Kiowski W., Buhler F.R., Luscher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation. 81:1990;1762-1767.
52. Taddei S., Virdis A., Mattei P., Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 21:1993;929-933.
53. Cardillo C., Kilcoyne C.M., Quyyumi A.A., Cannon R.O. 3rd, Panza J.A. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation. 97:1998;851-856.
54. Panza J.A., Casino P.R., Kilcoyne C.M., Quyyumi A.A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 87:1993;1468-1474.
55. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 88:1993;2541-2547.
56. Gilligan D.M., Guetta V., Panza J.A., Garcia C.E., Quyyumi A.A., Cannon R.O. III. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 90:1994;35-41.
57. Quyyumi A.A., Mulcahy D., Andrews N.P., Husain S., Panza J.A., Cannon R.O. III. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation. 95:1997;104-110.
58. Prasad A., Tupas-Habib T., Schenke W.H., Mincemoyer R., Panza J.A., Waclawin M.A., Ellahham S., Quyyumi A.A. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation. 101:2000;2349-2354.